TNGX as of Oct 31 · 11:05 ET
TNGXNasdaqPharmaceutical Preparations
Tango Therapeutics, Inc. · Brief
Next report
3 days
Nov 3 · before openest.Q3 FY26
Expected move
Inputs0 of 7≥ implied
- avg implied
- ±21.4%
- avg realized
- ±8.7%
Feb 27 '25±18.9%▼−6.44%×0.34
May 12 '25—▲+14.91%—
Aug 5 '25±17.5%▲+4.86%×0.28
Q3 FY25±15.0%0.00%×0.00
Jan 8 '26±30.3%▼−6.23%×0.21
Q1 FY26±42.5%▲+36.28%×0.85
May 13 '26±14.3%▼−2.51%×0.18
Q2 FY26±11.4%▼−4.81%×0.42
quarterimplied−45%0+45%realized×
Q2 FY26±11.4%▼−4.81%×0.42
May '26±14.3%▼−2.51%×0.18
Q1 FY26±42.5%▲+36.28%×0.85
Jan '26±30.3%▼−6.23%×0.21
Q3 FY25±15.0%0.00%×0.00
Aug '25±17.5%▲+4.86%×0.28
2 older reports
May '25—▲+14.91%—
Feb '25±18.9%▼−6.44%×0.34
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 3 report · est.Bull2
Bear2 of 3
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
TNGX report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.